Literature DB >> 30272597

Smoking and Helicobacter pylori infection: an individual participant pooled analysis (Stomach Cancer Pooling- StoP Project).

Ana Ferro1, Samantha Morais1, Claudio Pelucchi2, Nuria Aragonés3,4, Manolis Kogevinas4,5,6,7, Lizbeth López-Carrillo8, Reza Malekzadeh9, Shoichiro Tsugane10, Gerson S Hamada11, Akihisa Hidaka10, Raúl U Hernández-Ramírez8,12, Malaquias López-Cervantes13, David Zaridze14, Dmitry Maximovitch14, Farhad Pourfarzi9,15, Zuo-Feng Zhang16, Guo-Pei Yu17, Mohammadreza Pakseresht9,18,19, Weimin Ye20, Amelie Plymoth20, Marcis Leja21, Evita Gasenko21, Mohammad H Derakhshan9,22, Eva Negri23, Carlo La Vecchia2, Bárbara Peleteiro1,24, Nuno Lunet1,24.   

Abstract

Smoking has been associated with acquisition and increased persistence of Helicobacter pylori infection, as well as with lower effectiveness of its eradication. A greater prevalence of infection among smokers could contribute to the increased risk for gastric cancer. We aimed to estimate the association between smoking and seropositivity to H. pylori through an individual participant data pooled analysis using controls from 14 case-control studies participating in the Stomach Cancer Pooling Project. Summary odds ratios and prevalence ratios (PRs), adjusted for age, sex and social class, and the corresponding 95% confidence intervals (CIs) were estimated through random-effects meta-analysis. Heterogeneity was quantified using the I statistic and publication bias with Egger's test. There was no significant association between smoking (ever vs. never) and H. pylori seropositivity (adjusted odds ratio = 1.08; 95% CI: 0.89-1.32; adjusted PR = 1.01; 95% CI: 0.98-1.05). The strength of the association did not increase with the intensity or duration of smoking; stratified analyses according to sex, age, region or type of sample did not yield a consistent pattern of variation or statistically significant results, except for participants younger than 55 years and who had been smoking for more than 30 years (adjusted PR = 1.08; 95% CI: 1.02-1.15). This is the first collaborative analysis providing pooled estimates for the association between smoking and H. pylori seropositivity, based on detailed and uniform information and adjusting for major covariates. The results do not support an association between smoking and H. pylori infection.

Entities:  

Year:  2019        PMID: 30272597     DOI: 10.1097/CEJ.0000000000000471

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  4 in total

1.  The mediating role of combined lifestyle factors on the relationship between education and gastric cancer in the Stomach cancer Pooling (StoP) Project.

Authors:  Gianfranco Alicandro; Paola Bertuccio; Giulia Collatuzzo; Claudio Pelucchi; Rossella Bonzi; Linda M Liao; Charles S Rabkin; Rashmi Sinha; Eva Negri; Michela Dalmartello; David Zaridze; Dmitry Maximovich; Jesus Vioque; Manoli Garcia de la Hera; Shoichiro Tsugane; Akihisa Hidaka; Gerson Shigueaki Hamada; Lizbeth López-Carrillo; Raúl Ulises Hernández-Ramírez; Reza Malekzadeh; Farhad Pourfarzi; Zuo-Feng Zhang; Robert C Kurtz; M Constanza Camargo; Maria Paula Curado; Nuno Lunet; Paolo Boffetta; Carlo La Vecchia
Journal:  Br J Cancer       Date:  2022-05-27       Impact factor: 9.075

2.  Dietary Factors and the Risk of Gastric Cancer in Hanzhong Area of China.

Authors:  Cheng Wang; Sanjun He; Weimin Jin; Luanluan Zheng; Rui Jin; Sichuan Feng; Ying Zhou; Hanqiu Tang; Haixia Liu; Yi Si
Journal:  Iran J Public Health       Date:  2022-08       Impact factor: 1.479

3.  Sex differences in the relationship among alcohol, smoking, and Helicobacter pylori infection in asymptomatic individuals.

Authors:  Wenzhi Wu; Marcis Leja; Vladislav Tsukanov; Zarrin Basharat; Dong Hua; Wandong Hong
Journal:  J Int Med Res       Date:  2020-05       Impact factor: 1.671

4.  Associations between seroprevalence of Helicobacter pylori and ABO/rhesus blood group antigens in healthy blood donors in southwest Iran.

Authors:  Azar Dokht Khosravi; Mehrandokht Sirous; Morteza Saki; Sakineh Seyed-Mohammadi; Seyed Reza Modares Mousavi; Hojat Veisi; Asma Abbasinezhad Poor
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.